Cargando…

P1286: IMPAIRED ACTIVITY OF NATURAL KILLER CELLS IN DIFFUSE LARGE B-CELL LYMPHOMA MOST LIKELY ORIGINATES FROM LYMPHOMA-INDUCED MODULATION OF THEIR SURFACE RECEPTOR EXPRESSION

Detalles Bibliográficos
Autores principales:	Ringelstein-Harlev, S., Azoulay, T., Slouzkey, I., Karmona, M., Filatov, M., Sarig, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430799/ http://dx.doi.org/10.1097/01.HS9.0000848008.57032.7b

Ejemplares similares

P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS
por: Gurion, R., et al.
Publicado: (2022)

Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
por: Henig, Israel, et al.
Publicado: (2023)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

Primary Natural Killer/T-Cell Lymphoma of the Ribs
por: Kim, Kyoung Min, et al.
Publicado: (2023)

Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells
por: Qi, Jing, et al.
Publicado: (2022)

Reconstruction of a Rare Palate Defect Originating from Extranodal Natural Killer/T-Cell Lymphoma
por: Han, So-Eun, et al.
Publicado: (2013)

Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma
por: Liu, Jianyun, et al.
Publicado: (2018)

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
por: Gill, Harinder, et al.
Publicado: (2010)

Treatment outcome of nasal natural killer/T-cell lymphoma
por: Lee, Hyun Jin, et al.
Publicado: (2011)

Delayed Diagnosis of Nasal Natural Killer/T-Cell Lymphoma
por: Villwock, Jennifer A., et al.
Publicado: (2013)

Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand
por: Lim, Yoo Li, et al.
Publicado: (2015)

Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
por: Somasundaram, Nagavalli, et al.
Publicado: (2019)

Advances in multiple omics of natural-killer/T cell lymphoma
por: Xiong, Jie, et al.
Publicado: (2018)

Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
por: Althoff, Ashley, et al.
Publicado: (2017)

Non-coding RNAs in Natural Killer/T-Cell Lymphoma
por: Mei, Mei, et al.
Publicado: (2019)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma
por: Maeng, Young-In, et al.
Publicado: (2020)

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment
por: Pileri, Stefano A., et al.
Publicado: (2019)

Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma
por: Ogura, Michinori, et al.
Publicado: (2016)

Patients with Hodgkin Lymphoma Develop Adequate Humoral Serological Response to Vaccination with Two Doses of BNT162b2
por: Dann, Eldad J, et al.
Publicado: (2021)

First case of primary intraocular natural killer t-cell lymphoma
por: Maruyama, Kazuichi, et al.
Publicado: (2015)

Extranasal natural killer/T-cell lymphoma initially presenting as myelofibrosis
por: Jang, Woori, et al.
Publicado: (2016)

Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis
por: Zuhaimy, Hanis, et al.
Publicado: (2017)

Blastic natural killer cell lymphoma/leukaemia in a cat
por: Hirabayashi, Miyuki, et al.
Publicado: (2019)

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
por: Cai, Qingqing, et al.
Publicado: (2019)

Calreticulin increases growth and progression of natural killer/T-cell lymphoma
por: Zheng, Yan, et al.
Publicado: (2020)

Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma
por: Chan, Jason Yongsheng, et al.
Publicado: (2021)

Novel target and treatment agents for natural killer/T-cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE
por: Dann, E., et al.
Publicado: (2022)

Intraoral Extranodal Natural Killer Cell/T-Cell Lymphoma of the Hard Palate
por: Ahmadi-Motamayel, Fatemeh, et al.
Publicado: (2023)

Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway
por: Cui, Jieke, et al.
Publicado: (2022)

Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting
por: Ringelstein-Harlev, Shimrit, et al.
Publicado: (2014)

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma
por: Desai, Sanjal H., et al.
Publicado: (2022)

Gelsolin regulates proliferation, apoptosis and invasion in natural killer/T-cell lymphoma cells
por: Guo, Yanwei, et al.
Publicado: (2017)

Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis
por: Saleem, Atif, et al.
Publicado: (2020)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

Extranodal Natural Killer/T-Cell Lymphoma of the Nasal Type with Skin Metastases
por: Akhrass, Fadi Al, et al.
Publicado: (2016)

The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation
por: de Mel, Sanjay, et al.
Publicado: (2018)

Neurolymphomatosis Caused by Nasal-type Extranodal Natural Killer/T-cell Lymphoma
por: Yi, Fang-Fang, et al.
Publicado: (2017)

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
por: Li, Zhaoming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p02201v9ihmvjpt29tipnf0lnk